China's Huawei and WuXi AppTec collaborate on precision medicine cloud platform
23-Mar-16, Asian Scientist
Huawei, a leading global information and communications technology provider, and WuXi AppTec, the global open-access R&D platform, have announced the signing of a strategic framework agreement to support the China Precision Medicine Initiative (China PMI) through the creation of a precision medicine cloud platform.
%20Asian%20Scientist.jpg "Chinas Huawei and WuXi AppTec collaborate on precision medicine cloud platform (c) Asian Scientist")
Image: Asian Scientist
The agreement builds on Huawei’s capabilities and reach in cloud infrastructure, and the genomics and precision medicine expertise of WuXi NextCODE, the genomic information and precision medicine subsidiary of WuXi AppTec.
Cloud computing is the way genomic big data will be used to drive precision medicine innovation and deliver better healthcare in a cost-efficient manner. Huawei’s cloud platform serves 50,000 customers across China, with data centers in 15 cities. WuXi NextCODE genomics technology powers population genomics and large-scale precision medicine efforts in the UK, Qatar, US and China.